Related Experiment Video
Updated: Jun 10, 2025
00:05
Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
Published on: January 3, 2020
8.1K
Pancreatic insulinomas: Our 15-year surgical experience
Furkan Karahan1, Serkan Karaıslı2, Arif Atay2
1Departman of General Surgery, Erciş Şehit Rıdvan Çevik State Hospital, Van, Turkey.
Scottish Medical Journal
|October 16, 2024
Summary
Accurate localization of pancreatic insulinomas is key for successful surgery. Enucleation is recommended for suitable patients, offering high success rates and lower morbidity.
Area of Science:
- Endocrinology
- Surgical Oncology
- Gastroenterology
Background:
- Insulinomas are rare, typically benign pancreatic endocrine tumors.
- Surgery is the only curative treatment for insulinomas.
- This study focuses on perioperative management of sporadic, benign insulinomas.
Purpose of the Study:
- To review perioperative management experiences with sporadic, benign pancreatic insulinomas.
- To evaluate surgical outcomes and identify optimal management strategies.
Main Methods:
- Retrospective review of 19 patients undergoing surgery for insulinoma (2008-2023).
- Exclusion of malignant, invasive, or familial multiple endocrine neoplasia cases.
- Analysis of demographic, radiological, surgical, and outcome data.
Main Results:
- Hypoglycemia symptoms were most common.
- Preoperative localization achieved in 74% (CT), 88% (palpation/intraoperative ultrasound).
- Enucleation (53%) was most common; pancreatic fistula occurred in 17% (higher with enucleation but lower overall morbidity).
Conclusions:
- Accurate insulinoma localization is critical for surgical planning.
- Enucleation is recommended for suitable patients due to high success and low morbidity.
- Careful perioperative management is essential for optimal outcomes.
